利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

12 条记录 (耗时 0.022 秒)

    Herbal composition for angina pectoris, method to prepare same and uses thereof
    2.
    发明申请
    Herbal composition for angina pectoris, method to prepare same and uses thereof 有权
    心绞痛的草药组合物，其制备方法及其用途

    公开(公告)号：US20030152651A1

    公开(公告)日：2003-08-14

    申请号：US10210548

    申请日：2002-07-31

    申请人： Tianjin Tasly Pharmaceutical Co., Ltd., China

    发明人： Xijun Yan ,  Naifeng Wu ,  Zhixin Guo ,  Zhengliang Ye ,  Yan Liu

    IPC分类号： A61K035/78 ,  A61K031/045

    CPC分类号： A61K36/537 ,  A61K31/045 ,  A61K36/185 ,  A61K36/258 ,  A61K36/54 ,  A61K2300/00

    摘要： This invention provides compositions comprising extracts of Radix Salviae Miltiorrhizae, Radix Notoginseng and Borneol. Said compositions comprise notoginsenoside R1 and ginsenoside Rg1 which are active components for therapeutic applications. This invention also provides a method of preparation of the said compositions and a method of identification and determination of the amount of individual effective components of said compositions. Finally, this invention provides various uses of the compositions.

    摘要翻译： 本发明提供了含有丹参，三七和冰片的提取物的组合物。 所述组合物包含作为治疗应用的活性成分的三七皂苷R1和人参皂甙Rg1。 本发明还提供了所述组合物的制备方法和鉴定和测定所述组合物的各个有效成分的量的方法。 最后，本发明提供了组合物的各种用途。

    PHARMACEUTICAL COMPOSITION FOR TREATING DIABETES AND ITS PROCESS FOR PREPARATION
    5.
    发明申请
    PHARMACEUTICAL COMPOSITION FOR TREATING DIABETES AND ITS PROCESS FOR PREPARATION 有权
    用于治疗糖尿病的药物组合物及其制备方法

    公开(公告)号：US20100136150A1

    公开(公告)日：2010-06-03

    申请号：US12601236

    申请日：2008-07-28

    申请人： Xiaolin Tong ,  Yonghong Zhu ,  Shuiping Zhou ,  Xiuhui E ,  Shuangming Wang ,  Zhongting Xia

    发明人： Xiaolin Tong ,  Yonghong Zhu ,  Shuiping Zhou ,  Xiuhui E ,  Shuangming Wang ,  Zhongting Xia

    IPC分类号： A61K36/00 ,  A61P3/10

    CPC分类号： A61K36/233 ,  A61K36/428 ,  A61K36/539 ,  A61K36/708 ,  A61K36/71 ,  A61K36/718 ,  A61K36/736 ,  A61K36/75 ,  A61K36/8888

    摘要： The present invention relates to methods for preparing a pharmaceutical composition for treating diabetes mellitus and the pharmaceutical composition prepared by the methods. The pharmaceutical composition of the present invention comprises extracts of the following crude drugs: 5-40 weight parts of Radix Trichosanthis (Tianhuafen), 10-30 weight parts of Radix Bupleuri (Chaihu), 3-15 weight parts of Fructus Aurantii Immaturus (Zhishi), 1-6 weight parts of Radix et Rhizoma Rhei (Dahuang), 1-12 weight parts of Rhizoma Pinelliae (Banxia), 3-15 weight parts of Radix Scutellariae (Huangqin), 1-12 weight parts of Rhizoma Coptidis (Huanglian), 3-15 weight parts of Radix Paeoniae Alba (Baishao) and 5-20 weight parts of Fructus Mume (Wumei), and optionally comprises pharmaceutically acceptable excipient. Also, the pharmaceutical composition of the present invention can further comprise Fructus Crataegi (Shanzha). Additionally, the present invention discloses four methods for preparing the pharmaceutical composition.

    摘要翻译： 本发明涉及制备用于治疗糖尿病的药物组合物的方法和通过该方法制备的药物组合物。 本发明的药物组合物含有以下生药的提取物：5-40重量份的天竺葵，10-30重量份的柴胡（柴胡），3-15重量份的枸杞（Zhishi ），1-6重量份的Radix et Rhizoma Rhei（Dahuang），1-12重量份的Pinisiae（Banxia），3-15重量份黄芩（黄琴），1-12重量份黄连（黄连） ），3-15重量份的白芍（白沙）和5-20重量份的苦参（Wumei），并且任选地包含药学上可接受的赋形剂。 此外，本发明的药物组合物还可以含有山楂（山楂）。 另外，本发明公开了制备药物组合物的四种方法。

    Preparation and application of transhintotalphenolic acid
    6.
    发明授权
    Preparation and application of transhintotalphenolic acid 有权
    透皮酚酸的制备与应用

    公开(公告)号：US07641922B2

    公开(公告)日：2010-01-05

    申请号：US10515963

    申请日：2003-05-21

    申请人： Feng Wei ,  Hongshui Yue ,  Dekun Li ,  Jiangxiao Sun ,  Zhengliang Ye ,  Xu Li

    发明人： Feng Wei ,  Hongshui Yue ,  Dekun Li ,  Jiangxiao Sun ,  Zhengliang Ye ,  Xu Li

    IPC分类号： A61K36/00 ,  A61K36/537

    CPC分类号： A61K31/34 ,  A61K31/19 ,  C07D307/84

    摘要： A process for preparing tanshintotalphenolic acid and the use of the product are disclosed. The process comprises: tanshin is hot-extracted with water, the extract is separated and refined by polyamide column and macroporous adsorption resin column, and lyophilized to obtain tanshintotalphenolic acid. The yield of the final end product is more than 4 percent based on the amount of crude drug and the content of totalphenolic acid is more than 80 percent. The tanshintotalphenolic acid obtained can be used as the medicine for preventing and treating cerebrovascular and cardiovascular diseases and so on.

    摘要翻译： 公开了制备丹参酚酸的方法及其用途。 该方法包括：用水提取丹参，用聚酰胺柱和大孔吸附树脂柱分离精制提取物，冻干得到丹参酚酸。 最终产品的产率基于生药量大于4％，总酚酸含量大于80％。 获得的丹参酚酸可用作预防和治疗脑血管和心血管疾病的药物等。

    Pharmaceutical composition for the treatment of cardiovascular and cerebrovascular diseases
    9.
    发明授权
    Pharmaceutical composition for the treatment of cardiovascular and cerebrovascular diseases 有权
    用于治疗心血管和脑血管疾病的药物组合物

    公开(公告)号：US07438935B2

    公开(公告)日：2008-10-21

    申请号：US10572083

    申请日：2004-09-23

    申请人： Feng Wei ,  Dekun Li ,  Chongnian Luo ,  Hongshui Yue ,  Qingchuang Chen ,  Zhijuan Huang

    发明人： Feng Wei ,  Dekun Li ,  Chongnian Luo ,  Hongshui Yue ,  Qingchuang Chen ,  Zhijuan Huang

    IPC分类号： A61K36/25 ,  A61K36/537 ,  A61K36/00

    CPC分类号： A61K36/258 ,  A61K31/7048 ,  A61K36/00 ,  A61K36/481 ,  A61K36/537 ,  A61K2300/00

    摘要： The present invention discloses a pharmaceutical composition for the treatment of cardiovascular and cerebrovascular diseases which comprises Radix Salviae Miltiorrhizae extract 5.0%-70.0%, Radix Notoginseng extract 10.0%-85.0%, Radix Astragali extract 5.0%-70.0%, and Bomeol or oil of Lignum Dalbergiae Odoriferae 1.0%-15.0%. The composition is active against cerebral ischemia and myocardial ischemia. The effects are superior to total phenic acid of Radix Salviae Miltiorrhizae or total saponin of Radix Notoginseng respectively, or the combination thereof. The composition of the invention can provide various kinds of preparations by the addition of various accessories. Thus the invention provides a more effective and convenient composition of TCM effective sections and its preparations.

    摘要翻译： 本发明公开了一种用于治疗心血管和脑血管疾病的药物组合物，其含有百草丹提取物5.0％-70.0％，三七提取物10.0％-85.0％，黄芪提取物5.0％-70.0％，和Bomeol或 枸杞1.0％-15.0％。 该组合物对脑缺血和心肌缺血具有活性。 其效果优于三七总皂甙或总皂甙或其组合。 本发明的组合物可以通过添加各种附件来提供各种制剂。 因此，本发明提供了一种更有效，更方便的中药有效切片及其制备方法。

    Preparation for cardio-cerebral blood vessel diseases and its preparing method
    10.
    发明授权
    Preparation for cardio-cerebral blood vessel diseases and its preparing method 有权
    心脑血管病的制备及其制备方法

    公开(公告)号：US07396545B2

    公开(公告)日：2008-07-08

    申请号：US11522296

    申请日：2006-09-15

    申请人： Yiyu Cheng ,  Haijiang Zhang ,  Zhengliang Ye

    发明人： Yiyu Cheng ,  Haijiang Zhang ,  Zhengliang Ye

    IPC分类号： A61K36/254 ,  A61K36/258

    CPC分类号： A61K36/48 ,  A61K31/045 ,  A61K36/258 ,  A61K36/537 ,  A61K45/06 ,  A61K2300/00

    摘要： The present invention discloses a traditional Chinese medicine preparation for cardio-cerebral blood vessel diseases, it is prepared through extracting danshen and Notoginseng by lye, precipitating with alcohol, concentrating, and adding other medicine and excipients. Then using the HAPLY-MS and HAPLY fingerprint Atlas to characterize its Physicochemical properties completely. Using the fingerprint Atlas analysis method of the present invention, the structure and comparative content of biologically active component can be known. Characterization of the physical chemical properties of danshen and Notoginseng of traditional Chinese medicine preparation with this way is better than other methods of the prior art.

    摘要翻译： 本发明公开了一种用于心脑血管病的中药制剂，其通过用碱液提取丹参和三七，通过酒精沉淀，浓缩和添加其他药物和赋形剂制备。 然后使用HAPLY-MS和HAPLY指纹图谱来完全表征其物理化学性质。 使用本发明的指纹Atlas分析方法，可以知道生物活性成分的结构和比较内容。 用这种方法对中药制剂丹参和三七的物理化学性质进行表征比现有技术的其他方法更好。